Erlotinib Unknown Status Phase N/A Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Screening

IndicationsStatusPurposePhase
Unknown StatusScreeningNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00903292Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma